Innovent Announces the Phase 3 ORIENT-16 Study Results Published in JAMA Evaluating Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma

ROCKVILLE, Md. and SUZHOU, China, Dec. 6, 2023 /PRNewswire/ — Innovent Biologics, Inc. ("Innovent")…

Ransomware Dwell Time Hits Low of 24 Hours

Analysis from Secureworks annual State of The Threat Report shows ransomware median…

Cisco Redefines Cybersecurity Defense with Powerful, Portfolio-Wide Artificial Intelligence Capabilities

NEWS SUMMARY: The new Cisco AI Assistant for Security marks a major…

Australia's first Cannabis Psychedelic Therapy launches at the Nine Perfect Strangers resort in Byron Bay

SYDNEY, Dec. 6, 2023 /PRNewswire/ — Cannabis Psychedelics, an Australian company has…

Nearmap Announces Agreement to Acquire Betterview, a Complementary Property Intelligence and Risk Management Platform

Leading imagery intelligence provider strengthens and complements insurance solution with acquisition SALT…

OC&C Strategy Consultants Becomes A Certified B Corporation

SHANGHAI, Dec. 6, 2023 /PRNewswire/ — OC&C Strategy Consultants (OC&C), the global…

Black Excellence is the Focus of PRA Group's Newest Employee Resource Group

NORFOLK, Va., Dec. 6, 2023 /PRNewswire/ — Today, PRA Group (Nasdaq: PRAA), a global…

EdHeroes Leadership Program takes the educational field by storm

TRIESEN, Liechtenstein, Dec. 6, 2023 /PRNewswire/ — According to UNESCO’s Global Education…